Assessing the structural conservation of protein pockets to study functional and allosteric sites: implications for drug discovery

Panjkovich, Alejandro; Daura, Xavier
January 2010
BMC Structural Biology;2010, Vol. 10, p9
Academic Journal
Background: With the classical, active-site oriented drug-development approach reaching its limits, protein ligandbinding sites in general and allosteric sites in particular are increasingly attracting the interest of medicinal chemists in the search for new types of targets and strategies to drug development. Given that allostery represents one of the most common and powerful means to regulate protein function, the traditional drug discovery approach of targeting active sites can be extended by targeting allosteric or regulatory protein pockets that may allow the discovery of not only novel drug-like inhibitors, but activators as well. The wealth of available protein structural data can be exploited to further increase our understanding of allosterism, which in turn may have therapeutic applications. A first step in this direction is to identify and characterize putative effector sites that may be present in already available structural data. Results: We performed a large-scale study of protein cavities as potential allosteric and functional sites, by integrating publicly available information on protein sequences, structures and active sites for more than a thousand protein families. By identifying common pockets across different structures of the same protein family we developed a method to measure the pocket's structural conservation. The method was first parameterized using known active sites. We characterized the predicted pockets in terms of sequence and structural conservation, backbone flexibility and electrostatic potential. Although these different measures do not tend to correlate, their combination is useful in selecting functional and regulatory sites, as a detailed analysis of a handful of protein families shows. We finally estimated the numbers of potential allosteric or regulatory pockets that may be present in the data set, finding that pockets with putative functional and effector characteristics are widespread across protein families. Conclusions: Our results show that structurally conserved pockets are a common feature of protein families. The structural conservation of protein pockets, combined with other characteristics, can be exploited in drug discovery procedures, in particular for the selection of the most appropriate target protein and pocket for the design of drugs against entire protein families or subfamilies (e.g. for the development of broad-spectrum antimicrobials) or against a specific protein (e.g. in attempting to reduce side effects).


Related Articles

  • Allosteric Modulation of G Protein-Coupled Receptors. May, L.T.; Avlani, V.A.; Sexton, P.M.; Christopoulos, A. // Current Pharmaceutical Design;Jul2004, Vol. 10 Issue 17, p2003 

    G protein-coupled receptors (GPCRs) constitute the largest receptor superfamily in the human genome and represent the most common targets of drug action. Classic agonist and antagonist ligands that act at GPCRs tend to bind to the receptor's orthosteric site, that is, the site recognized by the...

  • Tandem Domains with Tuned Interactions Are a Powerful Biological Design Principle. Nussinov, Ruth; Tsai, Chung-Jung // PLoS Biology;11/30/2015, Vol. 13 Issue 12, p1 

    Allosteric effects of mutations, ligand binding, or post-translational modifications on protein function occur through changes to the protein’s shape, or conformation. In a cell, there are many copies of the same protein, all experiencing these perturbations in a dynamic fashion and...

  • Antioxidant and Biochemical Activities of Mixed Ligand Complexes. Joseph, J.; Rani, G. // Applied Biochemistry & Biotechnology;Jan2014, Vol. 172 Issue 2, p867 

    Novel 4-aminoantipyrine based mixed ligand metal complexes with the Schiff bases ofL(L-4(furanylmethyleneamino)-1,5-dimethyl-2-phenyl-1H-pyrazol-3(2H)-one and L/ L/ Lare 2-(2-chlorobenzylideneamino)phenol, 2-(3-chlorobenzylideneamino)phenol, 2-(4-chlorobenzylideneamino)phenol were synthesized....

  • C-Reactive Protein (CRP) and Autoimmune Disease: Facts and Conjectures. Szalai, Alexander J. // Clinical & Developmental Immunology;Sep-Dec2004, Vol. 11 Issue 3/4, p221 

    C-reactive protein (CRP) is a blood component comprised of five identical subunits with a combined molecular mass of 110kDa; in the presence of Ca+ it binds phosphocholine (PC) with high affinity Ligand-bound CRP activates complement and the protein reportedly binds various Fc receptors....

  • Chemerin Is an Antimicrobial Agent in Human Epidermis. Banas, Magdalena; Zabieglo, Katarzyna; Kasetty, Gopinath; Kapinska-Mrowiecka, Monika; Borowczyk, Julia; Drukala, Justyna; Murzyn, Krzysztof; Zabel, Brian A.; Butcher, Eugene C.; Schroeder, Jens M.; Schmidtchen, Artur; Cichy, Joanna // PLoS ONE;Mar2013, Vol. 8 Issue 3, p1 

    Chemerin, a chemoattractant ligand for chemokine-like receptor 1 (CMKLR1) is predicted to share similar tertiary structure with antibacterial cathelicidins. Recombinant chemerin has antimicrobial activity. Here we show that endogenous chemerin is abundant in human epidermis, and that inhibition...

  • Neuroscience: A positive for GABA. Bucci, Mirella // Nature Chemical Biology;Sep2013, Vol. 9 Issue 9, p529 

    The article presents information on a study on positive allosteric modulators (PAM), which found a clue that linked back to DBI.

  • Allosteric regulation and catalysis emerge via a common route. Goodey, Nina M; Benkovic, Stephen J // Nature Chemical Biology;Aug2008, Vol. 4 Issue 8, p474 

    Allosteric regulation of protein function is a mechanism by which an event in one place of a protein structure causes an effect at another site, much like the behavior of a telecommunications network in which a collection of transmitters, receivers and transceivers communicate with each other...

  • Exploiting protein flexibility to predict the location of allosteric sites. Panjkovich, Alejandro; Daura, Xavier // BMC Bioinformatics;2012, Vol. 13 Issue 1, p1 

    Background: Allostery is one of the most powerful and common ways of regulation of protein activity. However, for most allosteric proteins identified to date the mechanistic details of allosteric modulation are not yet well understood. Uncovering commonmechanistic patterns underlying...

  • An activity-based probe reveals dynamic protein-protein interactions mediating IGF-1R transactivation by the GABAB receptor. Xin LIN; Xin LI; Ming JIANG; Linhai CHEN; Chanjuan XU; Wenhua ZHANG; Han ZHAO; Bing SUN; Xiaoli XU; Fajun NAN; Jianfeng LIU // Biochemical Journal;5/ 1/2012, Vol. 443 Issue 3, p627 

    Many GPCRs (G-protein-coupled receptors) can activate RTKs (receptor tyrosine kinases) in the absence of RTK ligands, a phenomenon called transactivation. However, the underlying molecular mechanisms remain undefined. In the present study we investigate the molecular basis of GABAB (γ...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics